Drybench Patent.

Patent and exclusivity dates from January to June 2034 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from January to June 2034 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2034 July to December 2034

Listed patent expiry (444)

6 Jan 2034 · NDA 214231 · DASIGLUCAGON HYDROCHLORIDE
US 11,795,204, use patent
patent.txt lines 15,650, 15,652
Flags
use code U-3752
Product numbers
001, 002
6 Jan 2034 · NDA 214487 · AVACOPAN
US 8,906,938, substance and product patent
patent.txt line 15,814
Flags
substance product
Product numbers
001
8 Jan 2034 · NDA 214826 · LORAZEPAM
US 8,999,393, product and use patent
patent.txt lines 16,204–16,207
Flags
product use code U-3210
Product numbers
001, 002, 003, 004
9 Jan 2034 · NDA 209531 · NUSINERSEN SODIUM
US 9,926,559, use patent
patent.txt line 10,624
Flags
use code U-1943
Product numbers
001
12 Jan 2034 · NDA 021660 · PACLITAXEL
US 9,511,046, use patent
patent.txt line 670
Flags
use code U-1434
Product numbers
001
13 Jan 2034 · NDA 212295 · REMIMAZOLAM BESYLATE
US 9,827,251, use patent
patent.txt line 13,807
Flags
use code U-2968
Product numbers
001
17 Jan 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,337,927, use patent
patent.txt lines 19,297, 19,350, 19,403, 19,456, 19,509
Flags
use code U-3226
Product numbers
001, 002, 003, 004, 005
17 Jan 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,337,927, use patent
patent.txt lines 19,298, 19,351, 19,404, 19,457, 19,510
Flags
use code U-3227
Product numbers
001, 002, 003, 004, 005
17 Jan 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,337,927, use patent
patent.txt lines 19,299, 19,352, 19,405, 19,458, 19,511
Flags
use code U-3228
Product numbers
001, 002, 003, 004, 005
17 Jan 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,337,927, use patent
patent.txt lines 19,300, 19,353, 19,406, 19,459, 19,512
Flags
use code U-3230
Product numbers
001, 002, 003, 004, 005
18 Jan 2034 · NDA 207356 · AMIKACIN SULFATE
US 9,566,234, product and use patent
patent.txt line 7,258
Flags
product use code U-2415
Product numbers
001
21 Jan 2034 · NDA 219491 · ZOLIFLODACIN
US 8,889,671, substance and use patent
patent.txt line 21,784
Flags
substance use code U-4369
Product numbers
001
21 Jan 2034 · NDA 219491 · ZOLIFLODACIN
US 9,187,495, substance and use patent
patent.txt line 21,786
Flags
substance use code U-4369
Product numbers
001
21 Jan 2034 · NDA 219491 · ZOLIFLODACIN
US 9,540,394, use patent
patent.txt line 21,787
Flags
use code U-4369
Product numbers
001
21 Jan 2034 · NDA 219491 · ZOLIFLODACIN
US 9,839,641, use patent
patent.txt line 21,788
Flags
use code U-4369
Product numbers
001
23 Jan 2034 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 8,410,088, substance and product patent
patent.txt line 13,113
Flags
substance product
Product numbers
001
29 Jan 2034 · NDA 213137 · VOXELOTOR
US 9,248,199, use patent
patent.txt lines 14,676, 14,689
Flags
use code U-2676
Product numbers
001, 002
29 Jan 2034 · NDA 213137 · VOXELOTOR
US 9,248,199, use patent
patent.txt lines 14,677, 14,690
Flags
use code U-2715
Product numbers
001, 002
29 Jan 2034 · NDA 216157 · VOXELOTOR
US 9,248,199, use patent
patent.txt line 18,374
Flags
use code U-2676
Product numbers
001
29 Jan 2034 · NDA 216157 · VOXELOTOR
US 9,248,199, use patent
patent.txt line 18,375
Flags
use code U-2715
Product numbers
001
30 Jan 2034 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 10,039,779, substance and product and use patent
patent.txt line 5,909
Flags
substance product use code U-2369
Product numbers
001
30 Jan 2034 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 10,039,779, substance and product and use patent
patent.txt line 5,910
Flags
substance product use code U-2370
Product numbers
001
30 Jan 2034 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 10,039,779, substance and product and use patent
patent.txt line 5,943
Flags
substance product use code U-1470
Product numbers
002
30 Jan 2034 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 10,040,872, product patent
patent.txt line 7,055
Flags
product
Product numbers
001
30 Jan 2034 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 10,086,011, use patent
patent.txt lines 8,484, 8,514
Flags
use code U-1470
Product numbers
001, 002
30 Jan 2034 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 11,116,783, product and use patent
patent.txt lines 8,486, 8,516
Flags
product use code U-1470
Product numbers
001, 002
30 Jan 2034 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 9,757,406, product patent
patent.txt lines 8,512, 8,542
Flags
product
Product numbers
001, 002
30 Jan 2034 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 11,116,783, product and use patent
patent.txt line 9,814
Flags
product use code U-2039
Product numbers
001
30 Jan 2034 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 11,116,783, product and use patent
patent.txt line 9,815
Flags
product use code U-2040
Product numbers
001
30 Jan 2034 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 11,116,783, product and use patent
patent.txt lines 15,577, 15,605
Flags
product use code U-1470
Product numbers
001, 002
30 Jan 2034 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 11,707,479, product and use patent
patent.txt lines 15,579, 15,607
Flags
product use code U-1470
Product numbers
001, 002
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 10,278,918, product patent
patent.txt line 19,257
Flags
product
Product numbers
001
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 10,772,829, product patent
patent.txt line 19,258
Flags
product
Product numbers
001
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 11,090,261, product patent
patent.txt line 19,259
Flags
product
Product numbers
001
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 11,844,858, product patent
patent.txt line 19,261
Flags
product
Product numbers
001
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 12,350,366, product patent
patent.txt line 19,264
Flags
product
Product numbers
001
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 12,721,810, product patent
patent.txt line 19,267
Flags
product
Product numbers
001
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 12,734,126, use patent
patent.txt line 19,268
Flags
use code U-4604
Product numbers
001
31 Jan 2034 · NDA 217064 · PHENTOLAMINE MESYLATE
US 9,795,560, product patent
patent.txt line 19,269
Flags
product
Product numbers
001
2 Feb 2034 · NDA 208564 · ESTRADIOL
US 11,266,661, use patent
patent.txt lines 8,818, 8,850
Flags
use code U-2316
Product numbers
001, 002
2 Feb 2034 · NDA 208564 · ESTRADIOL
US 11,266,661, use patent
patent.txt lines 8,819, 8,851
Flags
use code U-2317
Product numbers
001, 002
4 Feb 2034 · NDA 202992 · TERIFLUNOMIDE
US 9,186,346, use patent
patent.txt lines 3,593, 3,599
Flags
use code U-1786
Product numbers
001, 002
7 Feb 2034 · NDA 050790 · CYCLOSPORINE
US 9,676,525, product patent
patent.txt line 2,143
Flags
product delist requested
Product numbers
002
7 Feb 2034 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 9,314,561, product patent
patent.txt line 2,593
Flags
product
Product numbers
001
8 Feb 2034 · NDA 207103 · PALBOCICLIB
US 10,723,730, substance and product patent
patent.txt lines 7,037, 7,041, 7,045
Flags
substance product
Product numbers
001, 002, 003
8 Feb 2034 · NDA 212436 · PALBOCICLIB
US 10,723,730, substance and product patent
patent.txt lines 13,967, 13,973, 13,979
Flags
substance product
Product numbers
001, 002, 003
11 Feb 2034 · NDA 204399 · TESTOSTERONE
US 8,785,426, product and use patent
patent.txt lines 4,660, 4,663
Flags
product use code U-1531
Product numbers
002, 003
11 Feb 2034 · NDA 204399 · TESTOSTERONE
US 9,295,675, product and use patent
patent.txt lines 4,661, 4,664
Flags
product use code U-1531
Product numbers
002, 003
11 Feb 2034 · NDA 204399 · TESTOSTERONE
US 9,662,340, product and use patent
patent.txt lines 4,662, 4,665
Flags
product use code U-1531
Product numbers
002, 003
11 Feb 2034 · NDA 209863 · TESTOSTERONE ENANTHATE
US 10,881,798, product patent
patent.txt lines 10,921, 10,944, 10,967
Flags
product
Product numbers
001, 002, 003
12 Feb 2034 · NDA 212576 · CEDAZURIDINE; DECITABINE
US 8,268,800, substance and use patent
patent.txt line 14,178
Flags
substance use code U-2864
Product numbers
001
12 Feb 2034 · NDA 212576 · CEDAZURIDINE; DECITABINE
US 8,268,800, substance and use patent
patent.txt line 14,179
Flags
substance use code U-2865
Product numbers
001
12 Feb 2034 · NDA 212576 · CEDAZURIDINE; DECITABINE
US 8,268,800, substance and use patent
patent.txt line 14,180
Flags
substance use code U-2866
Product numbers
001
12 Feb 2034 · NDA 212576 · CEDAZURIDINE; DECITABINE
US 8,268,800, substance and use patent
patent.txt line 14,181
Flags
substance use code U-2867
Product numbers
001
12 Feb 2034 · NDA 213004 · AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
US 10,238,606, product patent
patent.txt line 14,533
Flags
product
Product numbers
001
12 Feb 2034 · NDA 213004 · AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
US 11,135,172, product and use patent
patent.txt line 14,534
Flags
product use code U-2660
Product numbers
001
12 Feb 2034 · NDA 213004 · AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
US 11,931,463, product and use patent
patent.txt line 14,536
Flags
product use code U-3866
Product numbers
001
12 Feb 2034 · NDA 213004 · AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
US 9,050,263, product and use patent
patent.txt line 14,537
Flags
product use code U-2660
Product numbers
001
12 Feb 2034 · NDA 213004 · AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
US 9,498,445, product and use patent
patent.txt line 14,538
Flags
product use code U-2660
Product numbers
001
12 Feb 2034 · NDA 213004 · AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
US 9,603,806, product and use patent
patent.txt line 14,539
Flags
product use code U-2660
Product numbers
001
14 Feb 2034 · NDA 210326 · FULVESTRANT
US 10,188,663, product and use patent
patent.txt line 11,306
Flags
product use code U-2540
Product numbers
001
14 Feb 2034 · NDA 210326 · FULVESTRANT
US 9,833,459, product and use patent
patent.txt line 11,308
Flags
product use code U-2540
Product numbers
001
14 Feb 2034 · NDA 218614 · OLEZARSEN SODIUM
US 9,593,333, use patent
patent.txt line 21,144
Flags
use code U-4050
Product numbers
001
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,786
Flags
use code U-1957
Product numbers
001
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,787
Flags
use code U-2143
Product numbers
001
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,788
Flags
use code U-2641
Product numbers
001
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,789
Flags
use code U-3288
Product numbers
001
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,792
Flags
use code U-3289
Product numbers
002
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt lines 1,791, 1,794
Flags
use code U-1953
Product numbers
002, 003
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,795
Flags
use code U-1954
Product numbers
003
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,796
Flags
use code U-1955
Product numbers
003
17 Feb 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218, use patent
patent.txt line 1,797
Flags
use code U-3285
Product numbers
003
18 Feb 2034 · NDA 204819 · RIOCIGUAT
US 10,662,188, substance and product and use patent
patent.txt lines 5,017, 5,024, 5,031, 5,038, 5,045
Flags
substance product use code U-2834
Product numbers
001, 002, 003, 004, 005
18 Feb 2034 · NDA 204819 · RIOCIGUAT
US 10,662,188, substance and product and use patent
patent.txt lines 5,018, 5,025, 5,032, 5,039, 5,046
Flags
substance product use code U-2835
Product numbers
001, 002, 003, 004, 005
18 Feb 2034 · NDA 204819 · RIOCIGUAT
US 11,203,593, substance and product and use patent
patent.txt lines 5,019, 5,026, 5,033, 5,040, 5,047
Flags
substance product use code U-2834
Product numbers
001, 002, 003, 004, 005
18 Feb 2034 · NDA 204819 · RIOCIGUAT
US 11,203,593, substance and product and use patent
patent.txt lines 5,020, 5,027, 5,034, 5,041, 5,048
Flags
substance product use code U-2835
Product numbers
001, 002, 003, 004, 005
18 Feb 2034 · NDA 204819 · RIOCIGUAT
US 12,503,469, product and use patent
patent.txt lines 5,021, 5,028, 5,035, 5,042, 5,049
Flags
product use code U-2834
Product numbers
001, 002, 003, 004, 005
18 Feb 2034 · NDA 204819 · RIOCIGUAT
US 12,503,469, product and use patent
patent.txt lines 5,022, 5,029, 5,036, 5,043, 5,050
Flags
product use code U-2835
Product numbers
001, 002, 003, 004, 005
19 Feb 2034 · NDA 213871 · ABROCITINIB
US 9,545,405, substance and product patent
patent.txt lines 15,276, 15,279, 15,282
Flags
substance product
Product numbers
001, 002, 003
19 Feb 2034 · NDA 213871 · ABROCITINIB
US 9,549,929, use patent
patent.txt lines 15,277, 15,280, 15,283
Flags
use code U-3195
Product numbers
001, 002, 003
19 Feb 2034 · NDA 218764 · NERANDOMILAST
US 9,802,954, use patent
patent.txt lines 21,284, 21,291
Flags
use code U-4298
Product numbers
001, 002
24 Feb 2034 · NDA 218201 · COPPER
US 10,398,588, product and use patent
patent.txt line 20,896
Flags
product use code U-4155
Product numbers
001
24 Feb 2034 · NDA 218201 · COPPER
US 9,610,191, use patent
patent.txt line 20,905
Flags
use code U-4155
Product numbers
001
26 Feb 2034 · NDA 209510 · AMISULPRIDE
US 9,084,765, use patent
patent.txt lines 10,564, 10,580
Flags
use code U-1744
Product numbers
001, 002
26 Feb 2034 · NDA 209510 · AMISULPRIDE
US 9,084,765, use patent
patent.txt lines 10,565, 10,581
Flags
use code U-2754
Product numbers
001, 002
26 Feb 2034 · NDA 209510 · AMISULPRIDE
US 9,084,765, use patent
patent.txt lines 10,566, 10,582
Flags
use code U-3467
Product numbers
001, 002
27 Feb 2034 · NDA 212728 · RIMEGEPANT SULFATE
US 8,314,117, substance and product and use patent
patent.txt line 14,409
Flags
substance product use code U-2718
Product numbers
001
27 Feb 2034 · NDA 212728 · RIMEGEPANT SULFATE
US 8,314,117, substance and product and use patent
patent.txt line 14,410
Flags
substance product use code U-3142
Product numbers
001
27 Feb 2034 · NDA 217424 · BERDAZIMER SODIUM
US 9,855,211, product and use patent
patent.txt line 19,943
Flags
product use code U-3800
Product numbers
001
27 Feb 2034 · NDA 217424 · BERDAZIMER SODIUM
US 9,855,211, product and use patent
patent.txt line 19,944
Flags
product use code U-3801
Product numbers
001
28 Feb 2034 · NDA 203341 · BOSUTINIB MONOHYDRATE
US 11,103,497, use patent
patent.txt lines 3,771, 3,782, 3,793
Flags
use code U-3216
Product numbers
001, 002, 003
28 Feb 2034 · NDA 203341 · BOSUTINIB MONOHYDRATE
US 11,103,497, use patent
patent.txt lines 3,772, 3,783, 3,794
Flags
use code U-3217
Product numbers
001, 002, 003
28 Feb 2034 · NDA 215244 · ELAMIPRETIDE HYDROCHLORIDE
US 11,083,771, use patent
patent.txt line 16,597
Flags
use code U-4277
Product numbers
001
28 Feb 2034 · NDA 215244 · ELAMIPRETIDE HYDROCHLORIDE
US 11,083,772, use patent
patent.txt line 16,598
Flags
use code U-4277
Product numbers
001
28 Feb 2034 · NDA 215244 · ELAMIPRETIDE HYDROCHLORIDE
US 11,771,734, use patent
patent.txt line 16,599
Flags
use code U-4277
Product numbers
001
28 Feb 2034 · NDA 215244 · ELAMIPRETIDE HYDROCHLORIDE
US 12,268,724, use patent
patent.txt line 16,600
Flags
use code U-4277
Product numbers
001
28 Feb 2034 · NDA 215244 · ELAMIPRETIDE HYDROCHLORIDE
US 9,687,519, use patent
patent.txt line 16,602
Flags
use code U-4277
Product numbers
001
28 Feb 2034 · NDA 215973 · LENACAPAVIR SODIUM
US 9,951,043, substance and product and use patent
patent.txt line 18,108
Flags
substance product use code U-3507
Product numbers
001
28 Feb 2034 · NDA 215974 · LENACAPAVIR SODIUM
US 9,951,043, substance and product and use patent
patent.txt line 18,114
Flags
substance product use code U-3507
Product numbers
001
28 Feb 2034 · NDA 215974 · LENACAPAVIR SODIUM
US 9,951,043, substance and product and use patent
patent.txt line 18,115
Flags
substance product use code U-4602
Product numbers
001
28 Feb 2034 · NDA 217424 · BERDAZIMER SODIUM
US 11,285,098, product patent
patent.txt line 19,936
Flags
product
Product numbers
001
28 Feb 2034 · NDA 217729 · BOSUTINIB MONOHYDRATE
US 11,103,497, use patent
patent.txt lines 20,340, 20,350
Flags
use code U-3216
Product numbers
001, 002
28 Feb 2034 · NDA 217729 · BOSUTINIB MONOHYDRATE
US 11,103,497, use patent
patent.txt lines 20,341, 20,351
Flags
use code U-3217
Product numbers
001, 002
28 Feb 2034 · NDA 220018 · LENACAPAVIR SODIUM
US 9,951,043, substance and product and use patent
patent.txt line 22,083
Flags
substance product use code U-4190
Product numbers
001
28 Feb 2034 · NDA 220020 · LENACAPAVIR SODIUM
US 9,951,043, substance and product and use patent
patent.txt line 22,086
Flags
substance product use code U-4190
Product numbers
001
28 Feb 2034 · NDA 221104 · BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM
US 9,951,043, substance and product and use patent
patent.txt line 22,428
Flags
substance product use code U-4602
Product numbers
001
28 Feb 2034 · NDA 221443 · BICTEGRAVIR SODIUM, LENACAPAVIR SODIUM; LENACAPAVIR SODIUM
US 9,951,043, substance and product and use patent
patent.txt line 22,438
Flags
substance product use code U-4602
Product numbers
001
8 Mar 2034 · NDA 202971 · ARIPIPRAZOLE
US 10,525,057, use patent
patent.txt lines 3,520, 3,537, 3,554, 3,571
Flags
use code U-1632
Product numbers
001, 002, 003, 004
8 Mar 2034 · NDA 202971 · ARIPIPRAZOLE
US 10,525,057, use patent
patent.txt lines 3,521, 3,538, 3,555, 3,572
Flags
use code U-2723
Product numbers
001, 002, 003, 004
8 Mar 2034 · NDA 202971 · ARIPIPRAZOLE
US 10,525,057, use patent
patent.txt lines 3,522, 3,539, 3,556, 3,573
Flags
use code U-543
Product numbers
001, 002, 003, 004
12 Mar 2034 · NDA 019034 · HYDROMORPHONE HYDROCHLORIDE
US 9,248,229, product patent
patent.txt lines 143, 145, 147, 149, 151, 153, 155
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
12 Mar 2034 · NDA 204223 · MORPHINE SULFATE
US 9,072,781, product patent
patent.txt lines 4,352, 4,356, 4,360, 4,364, 4,368
Flags
product
Product numbers
001, 002, 003, 004, 005
12 Mar 2034 · NDA 204223 · MORPHINE SULFATE
US 9,192,608, use patent
patent.txt lines 4,353, 4,357, 4,361, 4,365, 4,369
Flags
use code U-43
Product numbers
001, 002, 003, 004, 005
12 Mar 2034 · NDA 204223 · MORPHINE SULFATE
US 9,192,608, use patent
patent.txt lines 4,354, 4,358, 4,362, 4,366, 4,370
Flags
use code U-55
Product numbers
001, 002, 003, 004, 005
12 Mar 2034 · NDA 204223 · MORPHINE SULFATE
US 9,248,229, product patent
patent.txt lines 4,355, 4,359, 4,363, 4,367, 4,371
Flags
product
Product numbers
001, 002, 003, 004, 005
12 Mar 2034 · NDA 213006 · VIBEGRON
US 12,180,219, substance and product patent
patent.txt line 14,565
Flags
substance product
Product numbers
001
12 Mar 2034 · NDA 215401 · DEXTROAMPHETAMINE
US 12,678,504, product and use patent
patent.txt lines 16,870, 16,874, 16,878, 16,882
Flags
product use code U-4583
Product numbers
001, 002, 003, 004
13 Mar 2034 · NDA 206255 · IVERMECTIN
US 10,206,939, use patent
patent.txt line 6,448
Flags
use code U-1631
Product numbers
001
13 Mar 2034 · NDA 206255 · IVERMECTIN
US 9,089,587, use patent
patent.txt line 6,449
Flags
use code U-1631
Product numbers
001
13 Mar 2034 · NDA 206255 · IVERMECTIN
US 9,233,117, use patent
patent.txt line 6,450
Flags
use code U-1631
Product numbers
001
13 Mar 2034 · NDA 206255 · IVERMECTIN
US 9,233,118, use patent
patent.txt line 6,451
Flags
use code U-1631
Product numbers
001
13 Mar 2034 · NDA 206255 · IVERMECTIN
US 9,782,425, use patent
patent.txt line 6,452
Flags
use code U-1631
Product numbers
001
13 Mar 2034 · NDA 209310 · MOMETASONE FUROATE
US 10,406,332, product patent
patent.txt line 10,073
Flags
product
Product numbers
001
13 Mar 2034 · NDA 211988 · BUPIVACAINE; MELOXICAM
US 10,398,686, product patent
patent.txt lines 13,313, 13,329, 13,345, 13,361
Flags
product
Product numbers
001, 002, 003, 004
13 Mar 2034 · NDA 211988 · BUPIVACAINE; MELOXICAM
US 11,253,504, use patent
patent.txt lines 13,319, 13,335, 13,351, 13,367
Flags
use code U-3118
Product numbers
001, 002, 003, 004
13 Mar 2034 · NDA 211988 · BUPIVACAINE; MELOXICAM
US 9,592,227, product and use patent
patent.txt lines 13,322, 13,338, 13,354, 13,370
Flags
product use code U-3118
Product numbers
001, 002, 003, 004
13 Mar 2034 · NDA 211988 · BUPIVACAINE; MELOXICAM
US 9,744,163, product patent
patent.txt lines 13,324, 13,340, 13,356, 13,372
Flags
product
Product numbers
001, 002, 003, 004
13 Mar 2034 · NDA 211988 · BUPIVACAINE; MELOXICAM
US 9,913,909, use patent
patent.txt lines 13,326, 13,342, 13,358, 13,374
Flags
use code U-3118
Product numbers
001, 002, 003, 004
14 Mar 2034 · NDA 206488 · ETEPLIRSEN
US 10,337,003, use patent
patent.txt lines 6,559, 6,566
Flags
use code U-1918
Product numbers
001, 002
14 Mar 2034 · NDA 206488 · ETEPLIRSEN
US 10,364,431, use patent
patent.txt lines 6,560, 6,567
Flags
use code U-1918
Product numbers
001, 002
14 Mar 2034 · NDA 206488 · ETEPLIRSEN
US 10,364,431, use patent
patent.txt lines 6,561, 6,568
Flags
use code U-1919
Product numbers
001, 002
14 Mar 2034 · NDA 206488 · ETEPLIRSEN
US 9,506,058, use patent
patent.txt lines 6,562, 6,569
Flags
use code U-1918
Product numbers
001, 002
14 Mar 2034 · NDA 206488 · ETEPLIRSEN
US 9,506,058, use patent
patent.txt lines 6,563, 6,570
Flags
use code U-1919
Product numbers
001, 002
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,420,841, use patent
patent.txt line 6,781
Flags
use code U-1672
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,420,841, use patent
patent.txt line 6,782
Flags
use code U-2631
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,420,841, use patent
patent.txt line 6,783
Flags
use code U-3360
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,420,841, use patent
patent.txt line 6,784
Flags
use code U-3361
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,420,841, use patent
patent.txt line 6,785
Flags
use code U-4546
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,420,841, use patent
patent.txt line 6,786
Flags
use code U-4547
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 11,278,622, use patent
patent.txt line 6,793
Flags
use code U-3335
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 11,278,622, use patent
patent.txt line 6,794
Flags
use code U-3336
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 11,278,622, use patent
patent.txt line 6,795
Flags
use code U-4542
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 11,278,622, use patent
patent.txt line 6,796
Flags
use code U-4543
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,968,753, use patent
patent.txt line 6,809
Flags
use code U-1672
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,968,753, use patent
patent.txt line 6,810
Flags
use code U-1673
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,968,753, use patent
patent.txt line 6,811
Flags
use code U-3360
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,968,753, use patent
patent.txt line 6,812
Flags
use code U-3361
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,968,753, use patent
patent.txt line 6,813
Flags
use code U-4547
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,968,753, use patent
patent.txt line 6,814
Flags
use code U-4550
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,320,740, product patent
patent.txt line 6,816
Flags
product
Product numbers
001
14 Mar 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,872,906, product patent
patent.txt line 6,823
Flags
product
Product numbers
001
14 Mar 2034 · NDA 207958 · LEVETIRACETAM
US 11,160,786, product patent
patent.txt lines 7,816, 7,821, 7,826, 7,831
Flags
product
Product numbers
001, 002, 003, 004
14 Mar 2034 · NDA 207958 · LEVETIRACETAM
US 9,339,489, product and use patent
patent.txt lines 7,817, 7,822, 7,827, 7,832
Flags
product use code U-1850
Product numbers
001, 002, 003, 004
14 Mar 2034 · NDA 207958 · LEVETIRACETAM
US 9,669,009, use patent
patent.txt lines 7,818, 7,823, 7,828, 7,833
Flags
use code U-1850
Product numbers
001, 002, 003, 004
14 Mar 2034 · NDA 207958 · LEVETIRACETAM
US 9,669,009, use patent
patent.txt lines 7,819, 7,824, 7,829, 7,834
Flags
use code U-2021
Product numbers
001, 002, 003, 004
14 Mar 2034 · NDA 207958 · LEVETIRACETAM
US 9,669,009, use patent
patent.txt lines 7,820, 7,825, 7,830, 7,835
Flags
use code U-2022
Product numbers
001, 002, 003, 004
14 Mar 2034 · NDA 208010 · CALCIFEDIOL
US 10,300,078, product patent
patent.txt line 7,949
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208010 · CALCIFEDIOL
US 10,357,502, product patent
patent.txt line 7,950
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208010 · CALCIFEDIOL
US 11,253,528, product patent
patent.txt line 7,952
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208010 · CALCIFEDIOL
US 9,861,644, product patent
patent.txt line 7,963
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208246 · TOFACITINIB CITRATE
US 10,639,309, product patent
patent.txt line 8,383
Flags
product
Product numbers
002
14 Mar 2034 · NDA 208246 · TOFACITINIB CITRATE
US 11,253,523, use patent
patent.txt lines 8,374, 8,385
Flags
use code U-3326
Product numbers
001, 002
14 Mar 2034 · NDA 208246 · TOFACITINIB CITRATE
US 11,253,523, use patent
patent.txt lines 8,375, 8,386
Flags
use code U-3327
Product numbers
001, 002
14 Mar 2034 · NDA 208246 · TOFACITINIB CITRATE
US 11,253,523, use patent
patent.txt lines 8,376, 8,387
Flags
use code U-3328
Product numbers
001, 002
14 Mar 2034 · NDA 208246 · TOFACITINIB CITRATE
US 11,253,523, use patent
patent.txt lines 8,377, 8,388
Flags
use code U-3329
Product numbers
001, 002
14 Mar 2034 · NDA 208246 · TOFACITINIB CITRATE
US 9,937,181, product patent
patent.txt line 8,379
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208254 · NETARSUDIL MESYLATE
US 10,588,901, substance and product and use patent
patent.txt line 8,394
Flags
substance product use code U-1524
Product numbers
001
14 Mar 2034 · NDA 208254 · NETARSUDIL MESYLATE
US 11,020,385, use patent
patent.txt line 8,397
Flags
use code U-1524
Product numbers
001
14 Mar 2034 · NDA 208254 · NETARSUDIL MESYLATE
US 11,185,538, product patent
patent.txt line 8,400
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208254 · NETARSUDIL MESYLATE
US 9,415,043, substance patent
patent.txt line 8,405
Flags
substance
Product numbers
001
14 Mar 2034 · NDA 208254 · NETARSUDIL MESYLATE
US 9,931,336, substance and product and use patent
patent.txt line 8,406
Flags
substance product use code U-1524
Product numbers
001
14 Mar 2034 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 10,588,901, substance and product and use patent
patent.txt line 8,409
Flags
substance product use code U-1524
Product numbers
001
14 Mar 2034 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 11,020,385, use patent
patent.txt line 8,412
Flags
use code U-1524
Product numbers
001
14 Mar 2034 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 11,185,538, product patent
patent.txt line 8,415
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 11,197,853, product patent
patent.txt line 8,416
Flags
product
Product numbers
001
14 Mar 2034 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 9,415,043, substance patent
patent.txt line 8,421
Flags
substance
Product numbers
001
14 Mar 2034 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 9,931,336, substance and product and use patent
patent.txt line 8,422
Flags
substance product use code U-1524
Product numbers
001
14 Mar 2034 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 9,993,470, substance and product and use patent
patent.txt line 8,423
Flags
substance product use code U-1524
Product numbers
001
14 Mar 2034 · NDA 208611 · DELAFLOXACIN MEGLUMINE
US 12,558,349, use patent
patent.txt line 8,915
Flags
use code U-3967
Product numbers
001
14 Mar 2034 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,286,029, use patent
patent.txt line 10,303
Flags
use code U-3237
Product numbers
001
14 Mar 2034 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,286,029, use patent
patent.txt line 10,304
Flags
use code U-4206
Product numbers
001
14 Mar 2034 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 11,484,534, use patent
patent.txt line 10,308
Flags
use code U-3237
Product numbers
001
14 Mar 2034 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 11,484,534, use patent
patent.txt line 10,309
Flags
use code U-4206
Product numbers
001
14 Mar 2034 · NDA 210450 · ELAGOLIX SODIUM
US 11,344,551, use patent
patent.txt line 11,395
Flags
use code U-3388
Product numbers
002
14 Mar 2034 · NDA 210450 · ELAGOLIX SODIUM
US 11,344,551, use patent
patent.txt line 11,396
Flags
use code U-3389
Product numbers
002
14 Mar 2034 · NDA 210450 · ELAGOLIX SODIUM
US 11,707,464, use patent
patent.txt line 11,392
Flags
use code U-3672
Product numbers
001
14 Mar 2034 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,446,260, use patent
patent.txt line 12,651
Flags
use code U-3444
Product numbers
001
14 Mar 2034 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,446,260, use patent
patent.txt line 12,652
Flags
use code U-3445
Product numbers
001
14 Mar 2034 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,446,260, use patent
patent.txt line 12,653
Flags
use code U-3446
Product numbers
001
14 Mar 2034 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,446,260, use patent
patent.txt line 12,654
Flags
use code U-4118
Product numbers
001
14 Mar 2034 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,446,260, use patent
patent.txt line 12,655
Flags
use code U-4119
Product numbers
001
14 Mar 2034 · NDA 213388 · ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
US 10,881,659, use patent
patent.txt line 14,968
Flags
use code U-2842
Product numbers
001
14 Mar 2034 · NDA 213388 · ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
US 11,045,470, use patent
patent.txt line 14,969
Flags
use code U-2842
Product numbers
001
14 Mar 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,085,992, use patent
patent.txt line 15,632
Flags
use code U-3081
Product numbers
001
14 Mar 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,966,984, use patent
patent.txt line 15,636
Flags
use code U-3079
Product numbers
001
14 Mar 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,966,984, use patent
patent.txt line 15,637
Flags
use code U-3080
Product numbers
001
14 Mar 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 11,717,523, use patent
patent.txt line 15,640
Flags
use code U-3678
Product numbers
001
14 Mar 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 11,717,523, use patent
patent.txt line 15,641
Flags
use code U-3679
Product numbers
001
14 Mar 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 9,487,530, use patent
patent.txt line 15,646
Flags
use code U-3079
Product numbers
001
14 Mar 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 9,487,530, use patent
patent.txt line 15,647
Flags
use code U-3080
Product numbers
001
14 Mar 2034 · NDA 214324 · TREPROSTINIL
US 12,679,811, use patent
patent.txt lines 15,680, 15,688, 15,696, 15,704, 15,712
Flags
use code U-1849
Product numbers
001, 002, 003, 004, 005
14 Mar 2034 · NDA 214324 · TREPROSTINIL
US 12,679,811, use patent
patent.txt lines 15,681, 15,689, 15,697, 15,705, 15,713
Flags
use code U-3749
Product numbers
001, 002, 003, 004, 005
14 Mar 2034 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 10,286,029, use patent
patent.txt line 16,483
Flags
use code U-3238
Product numbers
001
14 Mar 2034 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 10,286,029, use patent
patent.txt line 16,484
Flags
use code U-4206
Product numbers
001
14 Mar 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 10,383,846, use patent
patent.txt line 19,845
Flags
use code U-2398
Product numbers
001
14 Mar 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 9,220,707, use patent
patent.txt line 19,863
Flags
use code U-2398
Product numbers
001
14 Mar 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 9,492,429, product and use patent
patent.txt line 19,864
Flags
product use code U-2398
Product numbers
001
14 Mar 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 9,895,350, use patent
patent.txt line 19,865
Flags
use code U-2398
Product numbers
001
14 Mar 2034 · NDA 219304 · VIMSELTINIB
US 9,181,223, substance and product patent
patent.txt lines 21,606, 21,619, 21,632
Flags
substance product
Product numbers
001, 002, 003
14 Mar 2034 · NDA 219428 · CYCLOBENZAPRINE HYDROCHLORIDE
US 10,117,936, product patent
patent.txt line 21,735
Flags
product
Product numbers
001
14 Mar 2034 · NDA 219428 · CYCLOBENZAPRINE HYDROCHLORIDE
US 10,864,175, product patent
patent.txt line 21,736
Flags
product
Product numbers
001
14 Mar 2034 · NDA 219428 · CYCLOBENZAPRINE HYDROCHLORIDE
US 9,636,408, product patent
patent.txt line 21,737
Flags
product
Product numbers
001
14 Mar 2034 · NDA 219428 · CYCLOBENZAPRINE HYDROCHLORIDE
US 9,956,188, product patent
patent.txt line 21,738
Flags
product
Product numbers
001
17 Mar 2034 · NDA 205488 · TESTOSTERONE
US 11,090,312, use patent
patent.txt line 5,436
Flags
use code U-1616
Product numbers
001
17 Mar 2034 · NDA 205488 · TESTOSTERONE
US 11,744,838, use patent
patent.txt line 5,437
Flags
use code U-4366
Product numbers
001
17 Mar 2034 · NDA 205488 · TESTOSTERONE
US 11,744,838, use patent
patent.txt line 5,438
Flags
use code U-4367
Product numbers
001
17 Mar 2034 · NDA 210308 · ABIRATERONE ACETATE
US 9,889,144, product patent
patent.txt line 11,305
Flags
product
Product numbers
001
17 Mar 2034 · NDA 220605 · RUSFERTIDE ACETATE
US 10,030,061, substance and product patent
patent.txt lines 22,294, 22,300, 22,306, 22,312, 22,318
Flags
substance product
Product numbers
001, 002, 003, 004, 005
17 Mar 2034 · NDA 220605 · RUSFERTIDE ACETATE
US 10,442,846, substance and product and use patent
patent.txt lines 22,295, 22,301, 22,307, 22,313, 22,319
Flags
substance product use code U-4600
Product numbers
001, 002, 003, 004, 005
17 Mar 2034 · NDA 220605 · RUSFERTIDE ACETATE
US 10,501,515, substance and use patent
patent.txt lines 22,296, 22,302, 22,308, 22,314, 22,320
Flags
substance use code U-4600
Product numbers
001, 002, 003, 004, 005
17 Mar 2034 · NDA 220605 · RUSFERTIDE ACETATE
US 11,807,674, product and use patent
patent.txt lines 22,297, 22,303, 22,309, 22,315, 22,321
Flags
product use code U-4600
Product numbers
001, 002, 003, 004, 005
17 Mar 2034 · NDA 220605 · RUSFERTIDE ACETATE
US 12,269,856, use patent
patent.txt lines 22,298, 22,304, 22,310, 22,316, 22,322
Flags
use code U-4600
Product numbers
001, 002, 003, 004, 005
17 Mar 2034 · NDA 220605 · RUSFERTIDE ACETATE
US 9,822,157, substance and product patent
patent.txt lines 22,299, 22,305, 22,311, 22,317, 22,323
Flags
substance product
Product numbers
001, 002, 003, 004, 005
18 Mar 2034 · NDA 215498 · ODEVIXIBAT
US 9,694,018, use patent
patent.txt lines 17,322, 17,350, 17,378, 17,406
Flags
use code U-3186
Product numbers
001, 002, 003, 004
18 Mar 2034 · NDA 215498 · ODEVIXIBAT
US 9,694,018, use patent
patent.txt lines 17,323, 17,351, 17,379, 17,407
Flags
use code U-3648
Product numbers
001, 002, 003, 004
22 Mar 2034 · NDA 206229 · LEVONORGESTREL
US 10,028,858, product and use patent
patent.txt line 6,444
Flags
product use code U-2348
Product numbers
001
22 Mar 2034 · NDA 218201 · COPPER
US 10,022,264, product patent
patent.txt line 20,892
Flags
product
Product numbers
001
22 Mar 2034 · NDA 218201 · COPPER
US 9,180,040, product patent
patent.txt line 20,902
Flags
product
Product numbers
001
24 Mar 2034 · NDA 218585 · ACECLIDINE HYDROCHLORIDE
US 10,052,313, product and use patent
patent.txt line 21,122
Flags
product use code U-3741
Product numbers
001
24 Mar 2034 · NDA 218585 · ACECLIDINE HYDROCHLORIDE
US 11,179,328, use patent
patent.txt line 21,123
Flags
use code U-3741
Product numbers
001
24 Mar 2034 · NDA 218585 · ACECLIDINE HYDROCHLORIDE
US 9,844,537, product and use patent
patent.txt line 21,128
Flags
product use code U-3741
Product numbers
001
28 Mar 2034 · NDA 216578 · FEZOLINETANT
US 10,836,768, use patent
patent.txt line 18,864
Flags
use code U-3622
Product numbers
001
28 Mar 2034 · NDA 216578 · FEZOLINETANT
US 9,422,299, substance and product and use patent
patent.txt line 18,866
Flags
substance product use code U-3622
Product numbers
001
28 Mar 2034 · NDA 216578 · FEZOLINETANT
US 9,987,274, use patent
patent.txt line 18,867
Flags
use code U-3622
Product numbers
001
1 Apr 2034 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 10,206,895, product and use patent
patent.txt line 5,207
Flags
product use code U-2096
Product numbers
001
1 Apr 2034 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 10,206,895, product and use patent
patent.txt line 5,208
Flags
product use code U-2494
Product numbers
001
1 Apr 2034 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 11,013,703, product patent
patent.txt line 5,209
Flags
product
Product numbers
001
1 Apr 2034 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 12,290,495, use patent
patent.txt line 5,212
Flags
use code U-2096
Product numbers
001
1 Apr 2034 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 12,290,495, use patent
patent.txt line 5,213
Flags
use code U-2494
Product numbers
001
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 10,258,637, use patent
patent.txt lines 4,877, 4,912
Flags
use code U-2290
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,090,323, use patent
patent.txt lines 4,879, 4,914
Flags
use code U-3191
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,666,590, use patent
patent.txt line 4,880
Flags
use code U-3691
Product numbers
001
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,813,275, use patent
patent.txt line 4,882
Flags
use code U-3759
Product numbers
001
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,813,275, use patent
patent.txt line 4,883
Flags
use code U-3760
Product numbers
001
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,833,166, use patent
patent.txt lines 4,885, 4,916
Flags
use code U-3776
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,833,166, use patent
patent.txt lines 4,886, 4,917
Flags
use code U-3777
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,263,153, use patent
patent.txt lines 4,889, 4,920
Flags
use code U-4171
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,427,162, use patent
patent.txt lines 4,890, 4,921
Flags
use code U-4287
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,433,906, use patent
patent.txt lines 4,892, 4,923
Flags
use code U-4293
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,433,906, use patent
patent.txt lines 4,893, 4,924
Flags
use code U-4294
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,433,906, use patent
patent.txt lines 4,894, 4,925
Flags
use code U-4295
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,433,906, use patent
patent.txt lines 4,895, 4,926
Flags
use code U-4296
Product numbers
001, 002
3 Apr 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,433,906, use patent
patent.txt lines 4,896, 4,927
Flags
use code U-4304
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 10,258,637, use patent
patent.txt lines 6,174, 6,206
Flags
use code U-2290
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 11,090,323, use patent
patent.txt lines 6,178, 6,210
Flags
use code U-3191
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 11,833,166, use patent
patent.txt lines 6,180, 6,212
Flags
use code U-3776
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 11,833,166, use patent
patent.txt lines 6,181, 6,213
Flags
use code U-3777
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,433,906, use patent
patent.txt lines 6,188, 6,220
Flags
use code U-4293
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,433,906, use patent
patent.txt lines 6,189, 6,221
Flags
use code U-4294
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,433,906, use patent
patent.txt lines 6,190, 6,222
Flags
use code U-4295
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,433,906, use patent
patent.txt lines 6,191, 6,223
Flags
use code U-4296
Product numbers
001, 002
3 Apr 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,433,906, use patent
patent.txt lines 6,192, 6,224
Flags
use code U-4304
Product numbers
001, 002
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 10,258,637, use patent
patent.txt lines 6,291, 6,322, 6,353, 6,382
Flags
use code U-2290
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,090,323, use patent
patent.txt lines 6,295, 6,326, 6,357, 6,386
Flags
use code U-3193
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,666,590, use patent
patent.txt lines 6,296, 6,327, 6,358, 6,387
Flags
use code U-4154
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,813,275, use patent
patent.txt lines 6,298, 6,329
Flags
use code U-3759
Product numbers
001, 002
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,833,166, use patent
patent.txt lines 6,300, 6,331, 6,360, 6,389
Flags
use code U-3776
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,833,166, use patent
patent.txt lines 6,301, 6,332, 6,361, 6,390
Flags
use code U-3777
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,263,153, use patent
patent.txt lines 6,304, 6,335, 6,364, 6,393
Flags
use code U-4154
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,427,162, use patent
patent.txt lines 6,305, 6,336, 6,365, 6,394
Flags
use code U-4287
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 6,307, 6,338, 6,367, 6,396
Flags
use code U-4293
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 6,308, 6,339, 6,368, 6,397
Flags
use code U-4294
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 6,309, 6,340, 6,369, 6,398
Flags
use code U-4295
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 6,310, 6,341, 6,370, 6,399
Flags
use code U-4296
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 6,311, 6,342, 6,371, 6,400
Flags
use code U-4304
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 10,258,637, use patent
patent.txt lines 9,037, 9,069, 9,101, 9,131
Flags
use code U-2290
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,090,323, use patent
patent.txt lines 9,042, 9,074, 9,106, 9,136
Flags
use code U-3193
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,666,590, use patent
patent.txt lines 9,043, 9,075, 9,107, 9,137
Flags
use code U-4154
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,813,275, use patent
patent.txt lines 9,045, 9,077
Flags
use code U-3759
Product numbers
001, 002
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,833,166, use patent
patent.txt lines 9,047, 9,079, 9,109, 9,139
Flags
use code U-3776
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,833,166, use patent
patent.txt lines 9,048, 9,080, 9,110, 9,140
Flags
use code U-3777
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,263,153, use patent
patent.txt lines 9,051, 9,083, 9,113, 9,143
Flags
use code U-4154
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,427,162, use patent
patent.txt lines 9,052, 9,084, 9,114, 9,144
Flags
use code U-4287
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 9,054, 9,086, 9,116, 9,146
Flags
use code U-4293
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 9,055, 9,087, 9,117, 9,147
Flags
use code U-4294
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 9,056, 9,088, 9,118, 9,148
Flags
use code U-4295
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 9,057, 9,089, 9,119, 9,149
Flags
use code U-4296
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906, use patent
patent.txt lines 9,058, 9,090, 9,120, 9,150
Flags
use code U-4304
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 209988 · FUROSEMIDE
US 10,272,064, product patent
patent.txt line 11,089
Flags
product
Product numbers
001
3 Apr 2034 · NDA 209988 · FUROSEMIDE
US 11,433,044, use patent
patent.txt line 11,090
Flags
use code U-3462
Product numbers
001
3 Apr 2034 · NDA 209988 · FUROSEMIDE
US 12,370,168, product and use patent
patent.txt line 11,091
Flags
product use code U-3462
Product numbers
001
3 Apr 2034 · NDA 209988 · FUROSEMIDE
US 9,884,039, use patent
patent.txt line 11,092
Flags
use code U-3462
Product numbers
001
3 Apr 2034 · NDA 212154 · VILTOLARSEN
US 9,079,934, substance and product patent
patent.txt line 13,604
Flags
substance product
Product numbers
001
3 Apr 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 10,258,637, use patent
patent.txt lines 14,227, 14,257, 14,287, 14,317
Flags
use code U-2731
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,090,323, use patent
patent.txt lines 14,232, 14,262, 14,292, 14,322
Flags
use code U-3192
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,833,166, use patent
patent.txt lines 14,235, 14,265, 14,295, 14,324
Flags
use code U-3776
Product numbers
001, 002, 003, 004
3 Apr 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,833,166, use patent
patent.txt lines 14,236, 14,266, 14,296, 14,325
Flags
use code U-3777
Product numbers
001, 002, 003, 004
6 Apr 2034 · NDA 202971 · ARIPIPRAZOLE
US 11,648,347, product patent
patent.txt lines 3,534, 3,551, 3,568, 3,585
Flags
product
Product numbers
001, 002, 003, 004
6 Apr 2034 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 11,969,469, product patent
patent.txt lines 7,281, 7,298, 7,316, 7,334
Flags
product
Product numbers
001, 002, 003, 004
10 Apr 2034 · NDA 208772 · BRIGATINIB
US 9,611,283, use patent
patent.txt lines 9,318, 9,322, 9,326
Flags
use code U-2837
Product numbers
001, 002, 003
10 Apr 2034 · NDA 213931 · TENAPANOR HYDROCHLORIDE
US 10,272,079, use patent
patent.txt lines 15,303, 15,311, 15,319
Flags
use code U-3736
Product numbers
001, 002, 003
10 Apr 2034 · NDA 213931 · TENAPANOR HYDROCHLORIDE
US 10,272,079, use patent
patent.txt lines 15,304, 15,312, 15,320
Flags
use code U-381
Product numbers
001, 002, 003
10 Apr 2034 · NDA 213931 · TENAPANOR HYDROCHLORIDE
US 10,940,146, use patent
patent.txt lines 15,305, 15,313, 15,321
Flags
use code U-3736
Product numbers
001, 002, 003
10 Apr 2034 · NDA 213931 · TENAPANOR HYDROCHLORIDE
US 10,940,146, use patent
patent.txt lines 15,306, 15,314, 15,322
Flags
use code U-381
Product numbers
001, 002, 003
17 Apr 2034 · NDA 213411 · TUCATINIB
US 8,648,087, substance and product patent
patent.txt lines 14,986, 14,993
Flags
substance product
Product numbers
001, 002
17 Apr 2034 · NDA 213736 · PEMIGATINIB
US 10,131,667, use patent
patent.txt lines 15,224, 15,234, 15,244
Flags
use code U-2809
Product numbers
001, 002, 003
17 Apr 2034 · NDA 217369 · ZURANOLONE
US 10,172,871, use patent
patent.txt lines 19,866, 19,871, 19,876
Flags
use code U-2552
Product numbers
001, 002, 003
17 Apr 2034 · NDA 217369 · ZURANOLONE
US 10,342,810, use patent
patent.txt lines 19,867, 19,872, 19,877
Flags
use code U-2552
Product numbers
001, 002, 003
17 Apr 2034 · NDA 217369 · ZURANOLONE
US 9,512,165, substance and product patent
patent.txt lines 19,870, 19,875, 19,880
Flags
substance product
Product numbers
001, 002, 003
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 14,727
Flags
use code U-1745
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 14,728
Flags
use code U-2145
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 14,729
Flags
use code U-2537
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 14,730
Flags
use code U-2666
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 14,731
Flags
use code U-3063
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 14,732
Flags
use code U-3486
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 14,733
Flags
use code U-3860
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 14,735
Flags
product use code U-1745
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 14,736
Flags
product use code U-2145
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 14,737
Flags
product use code U-2537
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 14,738
Flags
product use code U-2666
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 14,739
Flags
product use code U-3063
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 14,740
Flags
product use code U-3486
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 14,741
Flags
product use code U-3860
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 14,788
Flags
substance product use code U-1745
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 14,789
Flags
substance product use code U-2145
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 14,790
Flags
substance product use code U-2537
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 14,791
Flags
substance product use code U-2666
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 14,792
Flags
substance product use code U-3063
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 14,793
Flags
substance product use code U-3486
Product numbers
001
22 Apr 2034 · NDA 213217 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 14,794
Flags
substance product use code U-3860
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 21,308
Flags
use code U-1745
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 21,309
Flags
use code U-2145
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 21,310
Flags
use code U-2537
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 21,311
Flags
use code U-2666
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 21,312
Flags
use code U-3063
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 21,313
Flags
use code U-3486
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 10,570,139, use patent
patent.txt line 21,314
Flags
use code U-3860
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 21,316
Flags
product use code U-1745
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 21,317
Flags
product use code U-2145
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 21,318
Flags
product use code U-2537
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 21,319
Flags
product use code U-2666
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 21,320
Flags
product use code U-3063
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 21,321
Flags
product use code U-3486
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 11,142,528, product and use patent
patent.txt line 21,322
Flags
product use code U-3860
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 21,370
Flags
substance product use code U-1745
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 21,371
Flags
substance product use code U-2145
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 21,372
Flags
substance product use code U-2537
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 21,373
Flags
substance product use code U-2666
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 21,374
Flags
substance product use code U-3063
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 21,375
Flags
substance product use code U-3486
Product numbers
001
22 Apr 2034 · NDA 218785 · ZANUBRUTINIB
US 9,447,106, substance and product and use patent
patent.txt line 21,376
Flags
substance product use code U-3860
Product numbers
001
23 Apr 2034 · NDA 215239 · VAMOROLONE
US 8,334,279, use patent
patent.txt line 16,596
Flags
use code U-3747
Product numbers
001
25 Apr 2034 · NDA 217202 · LANDIOLOL HYDROCHLORIDE
US 10,722,516, use patent
patent.txt line 19,804
Flags
use code U-4235
Product numbers
001
28 Apr 2034 · NDA 204153 · LULICONAZOLE
US 8,980,931, product patent
patent.txt line 4,333
Flags
product
Product numbers
001
28 Apr 2034 · NDA 218201 · COPPER
US 9,265,652, use patent
patent.txt line 20,903
Flags
use code U-4155
Product numbers
001
1 May 2034 · NDA 217388 · EPLONTERSEN SODIUM
US 9,127,276, substance patent
patent.txt lines 19,900, 19,903
Flags
substance
Product numbers
001, 002
1 May 2034 · NDA 217388 · EPLONTERSEN SODIUM
US 9,181,549, substance patent
patent.txt lines 19,901, 19,904
Flags
substance
Product numbers
001, 002
1 May 2034 · NDA 218614 · OLEZARSEN SODIUM
US 12,509,684, use patent
patent.txt line 21,137
Flags
use code U-4050
Product numbers
001
1 May 2034 · NDA 218614 · OLEZARSEN SODIUM
US 12,509,684, use patent
patent.txt lines 21,138, 21,145
Flags
use code U-4580
Product numbers
001, 002
1 May 2034 · NDA 218614 · OLEZARSEN SODIUM
US 9,127,276, substance patent
patent.txt lines 21,139, 21,146
Flags
substance
Product numbers
001, 002
1 May 2034 · NDA 218614 · OLEZARSEN SODIUM
US 9,163,239, substance patent
patent.txt lines 21,142, 21,148
Flags
substance
Product numbers
001, 002
1 May 2034 · NDA 218614 · OLEZARSEN SODIUM
US 9,181,549, substance patent
patent.txt lines 21,143, 21,149
Flags
substance
Product numbers
001, 002
1 May 2034 · NDA 219407 · DONIDALORSEN SODIUM
US 9,127,276, substance patent
patent.txt line 21,726
Flags
substance
Product numbers
001
1 May 2034 · NDA 219407 · DONIDALORSEN SODIUM
US 9,181,549, substance patent
patent.txt line 21,727
Flags
substance
Product numbers
001
2 May 2034 · NDA 211950 · TRIAMCINOLONE ACETONIDE
US 9,937,075, product patent
patent.txt line 13,249
Flags
product
Product numbers
001
2 May 2034 · NDA 213051 · SEMAGLUTIDE
US 10,278,923, use patent
patent.txt lines 14,580, 14,595, 14,610
Flags
use code U-2628
Product numbers
001, 002, 003
2 May 2034 · NDA 213051 · SEMAGLUTIDE
US 10,278,923, substance and product and use patent
patent.txt lines 14,624, 14,633, 14,642
Flags
substance product use code U-2628
Product numbers
004, 005, 006
2 May 2034 · NDA 213051 · SEMAGLUTIDE
US 12,239,739, substance and product and use patent
patent.txt lines 14,588, 14,603, 14,618, 14,628, 14,637, 14,646
Flags
substance product use code U-2628
Product numbers
001, 002, 003, 004, 005, 006
2 May 2034 · NDA 213051 · SEMAGLUTIDE
US 12,514,822, use patent
patent.txt lines 14,589, 14,604, 14,619, 14,630, 14,639, 14,648
Flags
use code U-2628
Product numbers
001, 002, 003, 004, 005, 006
2 May 2034 · NDA 218316 · SEMAGLUTIDE
US 10,278,923, use patent
patent.txt lines 20,933, 20,941, 20,949, 20,958
Flags
use code U-4389
Product numbers
001, 002, 003, 004
2 May 2034 · NDA 218316 · SEMAGLUTIDE
US 12,239,739, use patent
patent.txt lines 20,937, 20,945, 20,953, 20,962
Flags
use code U-4388
Product numbers
001, 002, 003, 004
6 May 2034 · NDA 220482 · CIPEPOFOL
US 10,729,666, product and use patent
patent.txt line 22,290
Flags
product use code U-4599
Product numbers
001
6 May 2034 · NDA 220482 · CIPEPOFOL
US 9,517,988, substance and use patent
patent.txt line 22,291
Flags
substance use code U-4599
Product numbers
001
9 May 2034 · NDA 215727 · COLCHICINE
US 10,130,585, use patent
patent.txt line 17,493
Flags
use code U-3642
Product numbers
001
11 May 2034 · NDA 050790 · CYCLOSPORINE
US 9,669,974, product patent
patent.txt line 2,142
Flags
product delist requested
Product numbers
002
12 May 2034 · NDA 213876 · HYDROCORTISONE
US 9,649,280, product and use patent
patent.txt lines 15,286, 15,289, 15,292, 15,295
Flags
product use code U-3075
Product numbers
001, 002, 003, 004
15 May 2034 · NDA 213973 · RIPRETINIB
US 8,461,179, substance and product patent
patent.txt line 15,392
Flags
substance product
Product numbers
001
17 May 2034 · NDA 204629 · EMPAGLIFLOZIN
US 9,949,997, use patent
patent.txt line 4,907
Flags
use code U-3199
Product numbers
001
17 May 2034 · NDA 204629 · EMPAGLIFLOZIN
US 9,949,997, use patent
patent.txt line 4,908
Flags
use code U-3325
Product numbers
001
17 May 2034 · NDA 204629 · EMPAGLIFLOZIN
US 9,949,997, use patent
patent.txt lines 4,906, 4,937
Flags
use code U-2292
Product numbers
001, 002
17 May 2034 · NDA 205677 · TASIMELTEON
US 9,730,910, use patent
patent.txt line 5,804
Flags
use code U-2085
Product numbers
001
17 May 2034 · NDA 205677 · TASIMELTEON
US 9,730,910, use patent
patent.txt line 5,805
Flags
use code U-3005
Product numbers
001
17 May 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,997, use patent
patent.txt lines 6,319, 6,350, 6,379, 6,408
Flags
use code U-3532
Product numbers
001, 002, 003, 004
17 May 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,997, use patent
patent.txt lines 6,320, 6,351, 6,380, 6,409
Flags
use code U-3533
Product numbers
001, 002, 003, 004
17 May 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,997, use patent
patent.txt lines 9,064, 9,096, 9,126, 9,156
Flags
use code U-3532
Product numbers
001, 002, 003, 004
17 May 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,997, use patent
patent.txt lines 9,065, 9,097, 9,127, 9,157
Flags
use code U-3533
Product numbers
001, 002, 003, 004
17 May 2034 · NDA 210326 · FULVESTRANT
US 9,271,990, product and use patent
patent.txt line 11,307
Flags
product use code U-2540
Product numbers
001
17 May 2034 · NDA 214517 · TASIMELTEON
US 9,730,910, use patent
patent.txt line 15,861
Flags
use code U-3005
Product numbers
001
20 May 2034 · NDA 210308 · ABIRATERONE ACETATE
US 10,292,990, use patent
patent.txt line 11,304
Flags
use code U-2535
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 10,947,192, use patent
patent.txt line 19,846
Flags
use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 10,952,990, use patent
patent.txt line 19,847
Flags
use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 10,959,983, use patent
patent.txt line 19,848
Flags
use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 10,961,191, use patent
patent.txt line 19,849
Flags
use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 11,026,919, product and use patent
patent.txt line 19,850
Flags
product use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 11,034,652, product and use patent
patent.txt line 19,851
Flags
product use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 11,052,067, product and use patent
patent.txt line 19,852
Flags
product use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 11,084,788, product and use patent
patent.txt line 19,853
Flags
product use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 12,156,865, product and use patent
patent.txt line 19,857
Flags
product use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 12,357,609, product and use patent
patent.txt line 19,858
Flags
product use code U-2398
Product numbers
001
22 May 2034 · NDA 217347 · SOFPIRONIUM BROMIDE
US 12,398,102, product and use patent
patent.txt line 19,859
Flags
product use code U-2398
Product numbers
001
23 May 2034 · NDA 208912 · DEXAMETHASONE
US 10,028,965, use patent
patent.txt line 9,610
Flags
use code U-2340
Product numbers
001
23 May 2034 · NDA 208912 · DEXAMETHASONE
US 10,159,683, product patent
patent.txt line 9,611
Flags
product
Product numbers
001
26 May 2034 · NDA 208078 · AMIFAMPRIDINE PHOSPHATE
US 10,793,893, use patent
patent.txt line 8,095
Flags
use code U-2956
Product numbers
001
28 May 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,906,898, substance and product patent
patent.txt line 6,807
Flags
substance product
Product numbers
001
28 May 2034 · NDA 213138 · FIDAXOMICIN
US 9,808,530, product patent
patent.txt line 14,701
Flags
product
Product numbers
001
29 May 2034 · NDA 205437 · APREMILAST
US 10,092,541, use patent
patent.txt lines 5,398, 5,410, 5,422
Flags
use code U-2403
Product numbers
001, 002, 003
29 May 2034 · NDA 205437 · APREMILAST
US 10,092,541, use patent
patent.txt lines 5,399, 5,411, 5,423
Flags
use code U-2659
Product numbers
001, 002, 003
29 May 2034 · NDA 205437 · APREMILAST
US 9,872,854, use patent
patent.txt lines 5,407, 5,419, 5,431
Flags
use code U-2232
Product numbers
001, 002, 003
29 May 2034 · NDA 205437 · APREMILAST
US 9,872,854, use patent
patent.txt lines 5,408, 5,420, 5,432
Flags
use code U-2233
Product numbers
001, 002, 003
29 May 2034 · NDA 210745 · APREMILAST
US 10,092,541, use patent
patent.txt line 12,129
Flags
use code U-2659
Product numbers
001
2 Jun 2034 · NDA 208611 · DELAFLOXACIN MEGLUMINE
US 12,036,219, use patent
patent.txt line 8,913
Flags
use code U-3967
Product numbers
001
4 Jun 2034 · NDA 215192 · VADADUSTAT
US 12,569,474, use patent
patent.txt lines 16,521, 16,535, 16,549
Flags
use code U-3876
Product numbers
001, 002, 003
5 Jun 2034 · NDA 208745 · PLECANATIDE
US 10,011,637, substance patent
patent.txt line 9,303
Flags
substance
Product numbers
001
5 Jun 2034 · NDA 208745 · PLECANATIDE
US 11,142,549, product patent
patent.txt line 9,304
Flags
product
Product numbers
001
5 Jun 2034 · NDA 208745 · PLECANATIDE
US 11,834,521, product patent
patent.txt line 9,306
Flags
product
Product numbers
001
5 Jun 2034 · NDA 208745 · PLECANATIDE
US 12,146,003, product patent
patent.txt line 9,307
Flags
product
Product numbers
001
9 Jun 2034 · NDA 215192 · VADADUSTAT
US 11,857,543, use patent
patent.txt lines 16,520, 16,534, 16,548
Flags
use code U-3876
Product numbers
001, 002, 003
11 Jun 2034 · NDA 204629 · EMPAGLIFLOZIN
US 9,949,998, use patent
patent.txt lines 4,910, 4,939
Flags
use code U-2290
Product numbers
001, 002
11 Jun 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 9,949,998, use patent
patent.txt lines 6,204, 6,236
Flags
use code U-2290
Product numbers
001, 002
11 Jun 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,998, use patent
patent.txt lines 9,067, 9,099, 9,129, 9,159
Flags
use code U-2290
Product numbers
001, 002, 003, 004
11 Jun 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,949,998, use patent
patent.txt lines 14,254, 14,284, 14,314, 14,343
Flags
use code U-2731
Product numbers
001, 002, 003, 004
12 Jun 2034 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 12,162,865, use patent
patent.txt line 13,106
Flags
use code U-2736
Product numbers
001
13 Jun 2034 · NDA 218201 · COPPER
US 10,166,141, product patent
patent.txt line 20,894
Flags
product
Product numbers
001
17 Jun 2034 · NDA 203389 · CYSTEAMINE BITARTRATE
US 9,173,851, product patent
patent.txt lines 3,816, 3,840
Flags
product
Product numbers
001, 002
17 Jun 2034 · NDA 203389 · CYSTEAMINE BITARTRATE
US 9,233,077, product patent
patent.txt lines 3,822, 3,846
Flags
product
Product numbers
001, 002
17 Jun 2034 · NDA 207981 · TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
US 10,457,666, substance and product patent
patent.txt lines 7,891, 7,903
Flags
substance product
Product numbers
001, 002
17 Jun 2034 · NDA 207981 · TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
US 9,527,833, substance and product patent
patent.txt lines 7,896, 7,908
Flags
substance product
Product numbers
001, 002
17 Jun 2034 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 10,646,456, use patent
patent.txt lines 9,615, 9,632
Flags
use code U-2808
Product numbers
001, 002
17 Jun 2034 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 11,903,908, use patent
patent.txt lines 9,621, 9,638
Flags
use code U-3822
Product numbers
001, 002
17 Jun 2034 · NDA 213491 · CYSTEAMINE BITARTRATE
US 9,173,851, product patent
patent.txt lines 15,031, 15,055
Flags
product
Product numbers
001, 002
17 Jun 2034 · NDA 213491 · CYSTEAMINE BITARTRATE
US 9,233,077, product patent
patent.txt lines 15,037, 15,061
Flags
product
Product numbers
001, 002
19 Jun 2034 · NDA 214998 · MAVACAMTEN
US 9,585,883, use patent
patent.txt lines 16,409, 16,411, 16,413, 16,415
Flags
use code U-3373
Product numbers
001, 002, 003, 004
20 Jun 2034 · NDA 214783 · BELUMOSUDIL MESYLATE
US 8,357,693, substance and product and use patent
patent.txt line 16,120
Flags
substance product use code U-4259
Product numbers
001
22 Jun 2034 · NDA 206192 · COBIMETINIB FUMARATE
US 11,087,354, use patent
patent.txt line 6,436
Flags
use code U-1776
Product numbers
001
22 Jun 2034 · NDA 208912 · DEXAMETHASONE
US 10,022,502, use patent
patent.txt line 9,609
Flags
use code U-2340
Product numbers
001
23 Jun 2034 · NDA 209589 · CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US 10,624,879, product patent
patent.txt line 10,657
Flags
product
Product numbers
001
23 Jun 2034 · NDA 209589 · CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US 11,191,753, use patent
patent.txt line 10,658
Flags
use code U-3261
Product numbers
001
23 Jun 2034 · NDA 209589 · CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US 12,576,072, product and use patent
patent.txt line 10,660
Flags
product use code U-3261
Product numbers
001
26 Jun 2034 · NDA 209589 · CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US 9,827,231, product and use patent
patent.txt line 10,661
Flags
product use code U-2162
Product numbers
001
26 Jun 2034 · NDA 216386 · ZAVEGEPANT HYDROCHLORIDE
US 8,481,546, substance and product and use patent
patent.txt line 18,764
Flags
substance product use code U-3555
Product numbers
001
27 Jun 2034 · NDA 208325 · ETELCALCETIDE
US 10,344,765, product patent
patent.txt lines 8,459, 8,467, 8,475
Flags
product
Product numbers
001, 002, 003
27 Jun 2034 · NDA 208325 · ETELCALCETIDE
US 11,162,500, product patent
patent.txt lines 8,460, 8,468, 8,476
Flags
product
Product numbers
001, 002, 003
27 Jun 2034 · NDA 208325 · ETELCALCETIDE
US 11,959,486, product and use patent
patent.txt lines 8,461, 8,469, 8,477
Flags
product use code U-2014
Product numbers
001, 002, 003
27 Jun 2034 · NDA 208325 · ETELCALCETIDE
US 9,820,938, product patent
patent.txt lines 8,466, 8,474, 8,482
Flags
product
Product numbers
001, 002, 003

Pediatric exclusivity, as listed (21)

16 Feb 2034 · NDA 202811 · LINACLOTIDE
US 9,708,371 with pediatric exclusivity, as listed
patent.txt lines 3,343, 3,357, 3,373
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Feb 2034 · NDA 205552 · IBRUTINIB
US 9,540,382 with pediatric exclusivity, as listed
patent.txt lines 5,549, 5,647
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Feb 2034 · NDA 202806 · DABRAFENIB MESYLATE
US 10,869,869 with pediatric exclusivity, as listed
patent.txt lines 3,250, 3,274
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Feb 2034 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 10,869,869 with pediatric exclusivity, as listed
patent.txt lines 4,271, 4,291, 4,311
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Mar 2034 · NDA 208082 · DEUTETRABENAZINE
US 11,666,566 with pediatric exclusivity, as listed
patent.txt lines 8,125, 8,157, 8,189
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Mar 2034 · NDA 208082 · DEUTETRABENAZINE
US 9,233,959 with pediatric exclusivity, as listed
patent.txt lines 8,134, 8,166, 8,198
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Mar 2034 · NDA 208082 · DEUTETRABENAZINE
US 9,296,739 with pediatric exclusivity, as listed
patent.txt lines 8,136, 8,168, 8,200
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Mar 2034 · NDA 208082 · DEUTETRABENAZINE
US 9,550,780 with pediatric exclusivity, as listed
patent.txt lines 8,138, 8,170, 8,202
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Mar 2034 · NDA 208082 · DEUTETRABENAZINE
US 9,814,708 with pediatric exclusivity, as listed
patent.txt lines 8,141, 8,173, 8,205
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Mar 2034 · NDA 216354 · DEUTETRABENAZINE
US 9,550,780 with pediatric exclusivity, as listed
patent.txt lines 18,551, 18,581, 18,611, 18,641, 18,671, 18,701, 18,731, 18,761
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
23 Apr 2034 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,066,856 with pediatric exclusivity, as listed
patent.txt line 5,288
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
23 Apr 2034 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,486,406 with pediatric exclusivity, as listed
patent.txt line 5,290
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
30 Apr 2034 · NDA 205552 · IBRUTINIB
US 9,296,753 with pediatric exclusivity, as listed
patent.txt line 5,547
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
30 Apr 2034 · NDA 205552 · IBRUTINIB
US 9,296,753 with pediatric exclusivity, as listed
patent.txt line 5,645
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
002
30 Apr 2034 · NDA 210563 · IBRUTINIB
US 9,296,753 with pediatric exclusivity, as listed
patent.txt lines 11,677, 11,781, 11,885, 11,994
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
30 Apr 2034 · NDA 217003 · IBRUTINIB
US 9,296,753 with pediatric exclusivity, as listed
patent.txt line 19,220
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001
14 May 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 10,874,616 with pediatric exclusivity, as listed
patent.txt lines 19,292, 19,345, 19,398, 19,451, 19,504
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
14 May 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864 with pediatric exclusivity, as listed
patent.txt lines 19,301, 19,354, 19,407, 19,460, 19,513
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
14 May 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865 with pediatric exclusivity, as listed
patent.txt lines 19,306, 19,359, 19,412, 19,465, 19,518
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
14 May 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717 with pediatric exclusivity, as listed
patent.txt lines 19,313, 19,366, 19,419, 19,472, 19,525
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
30 May 2034 · NDA 205437 · APREMILAST
US 12,576,034 with pediatric exclusivity, as listed
patent.txt lines 5,400, 5,412, 5,424
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003

Non-patent exclusivity (2)

22 Feb 2034 · NDA 216165 · CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM
GAIN exclusivity
exclusivity.txt line 1,734
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001
3 Apr 2034 · NDA 218275 · CEFTOBIPROLE MEDOCARIL SODIUM
GAIN exclusivity
exclusivity.txt line 2,135
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001